NewLink Genetics Corp (NASDAQ:NLNK) - Share price - Overview

Stock Report

NewLink Genetics Corp NLNK

Last Price
$7.00

Day Change
-0.35|-4.76%

As of 27/07/2017
17:05:07 EDT | USD
Minimum 15 Minutes Delay.

Last Close7.35
Day Range6.97 - 7.40
Mkt Cap204.60Mil
52-Wk Range5.90 - 25.17
Yield %-
ISINUS6515111077
Volume566,348
P/E-2.46
P/S6.20
P/CF-3.42

Share Price

Financials
201420152016
More ...
Income Statement
Revenue172.5968.5035.77
Operating Income117.57-33.60-90.76
Net Income102.86-40.38-85.16
Basic EPS3.69-1.41-2.94
Avg. Diluted Shares Outstanding312929
Balance Sheet
Current Assets230.46208.14167.91
Non Current Assets7.6010.406.84
Total Assets238.06218.54174.75
Current Liabilities25.0214.8437.91
Total Liabilities34.2922.7745.28
Total Equity203.78195.77129.47
Cash Flow
Operating Cash Flow109.07-24.09-65.95
Capital Expenditure-1.70-4.00-2.25
Free Cash Flow107.37-28.08-68.19

In millions, except "Basic EPS". Currency is USD.

Company Profile

NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

122
Key Stats
More ...
Price/Earning TTM-2.59
Price/Book1.88
Price/Sales TTM6.51
Rev Growth (3 year avg)219.86
EPS Growth (3 year avg)-
Operating Margin % TTM-253.74
Net Margin % TTM-238.08
ROE TTM-52.36
Debt/Equity0.00
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.